The Cellular and Humoral Immune Response to SARS-CoV-2 Messenger RNA Vaccines Is Significantly Better in Liver Transplant Patients Compared with Kidney Transplant Patients

The Cellular and Humoral Immune Response to SARS-CoV-2 Messenger RNA Vaccines Is Significantly Better in Liver Transplant Patients Compared with Kidney Transplant Patients

Patients after organ transplantation have impaired immune response after vaccination against the SARS-CoV-2 virus. So far, published studies have reported quite different response rates to SARS-CoV-2 vaccination, ranging from 15–79% in liver and kidney transplant recipients. Up to one year after the...

Full beskrivning

Bibliografiska uppgifter
Huvudupphovsmän: Anja Lautem, Simone Cosima Boedecker-Lips, Elisa Schneider, Stefan Runkel, Christina Feist, Hauke Lang, Julia Weinmann-Menke, Martina Koch
Materialtyp: Artikel
Språk:English
Publicerad: MDPI AG 2023-07-01
Serie:Pathogens
Ämnen:
SARS-CoV-2
transplantation
immunosuppression
immune response
vaccination
Länkar:https://www.mdpi.com/2076-0817/12/7/910

Internet

https://www.mdpi.com/2076-0817/12/7/910

Liknande verk